The copy number variant involving part of the α7 nicotinic receptor gene contains a polymorphic inversion.
- Authors: Flomen, R.; Davies, A.; Di Forti, M.; LA CASCIA, C.; Macie Ogilvie, C.; Murray, R.; Makoff, A.; European Journal of Human Genetics, ; 1 8, 2.
- Publication year: 2008
- Type: Articolo in rivista (Articolo in rivista)
- OA Link: http://hdl.handle.net/10447/55175
Abstract
The α7 nicotinic acetylcholine receptor gene (CHRNA7) is located at 15q13–q14 in a region that is strongly linked to the P50 sensory gating deficit, an endophenotype of schizophrenia and bipolar disorder. Part of the gene is a copy number variant, due to a duplication of exons 5–10 and 3′ sequence in CHRFAM7A, which is present in many but not all humans. Maps of this region show that the two genes are in opposite orientation in the individual mainly represented in the public access human DNA sequence database (Build 36), suggesting that an inversion had occurred since the duplication. We have used fluorescent in situ hybridization to investigate this putative inversion. Analysis of interphase chromosomes in 12 individuals confirms the occurrence of an inversion and indicates that CHRFAM7A exists in both orientations with similar frequency. We showed that the 2 bp deletion polymorphism in exon 6 of CHRFAM7A is in strong linkage disequilibrium with the inversion polymorphism (r2=0.82, CI 0.53–1.00, P=0.00003), which can therefore be used as a surrogate marker. Previous associations of endophenotypes of schizophrenia with the 2 bp deletion might therefore be due to the orientation of the duplicon containing CHRFAM7A.